Drug Manufacturers - General · Healthcare
Dean Li
Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsAbout Dean Li
The proxy statement of Merck & Co., Inc. reports total compensation of $8,892,881 for Dean Li in fiscal 2025, including a base salary of $1,460,000. Disclosed compensation is on record for 7 fiscal years. Dean Li has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Merck & Co., Inc. on June 9, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.
Dean Li on recent calls
“Yeah, so one has to be a little bit thoughtful how one does it, but this is in the PD-L1 high. It is looking at the addition of a Trope-2 ADC with PD-1.”
“Progress continued with a steady cadence of clinical and regulatory development. Today, I will provide updates in cardiometabolic and respiratory, oncology, infectious diseases, and ophthalmology, then conclude with key upcoming milestones.”
“Progress continues across programs spanning multiple therapeutic areas. Today, I will provide updates across cardiometabolic and respiratory, infectious disease, and oncology programs, then conclude with a summary of highlights from 2025 and upcoming milestones for this year.”
Affiliation history
-
Merck & Co., Inc. (MRK)
Source not stated
Current
Company network
Leadership on record at Merck & Co., Inc.
- Robert M. Davis CEO, Chairman, Board Member
- Jennifer Zachary General Counsel
- Dalton E. Smart III Chief Accounting Officer
- Christine E. Seidman Board Member
- J.H. Noseworthy Board Member
- Kathy J. Warden Board Member
- P.B. Rothman Board Member
- P.J. Craig Board Member
- Paul J. Diaz Board Member
- R.B. Lazarus Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | $1,460,000 | $8,892,881 |
| 2024 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | $1,451,077 | $10,086,332 |
| 2023 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | $1,368,819 | $9,779,414 |
| 2022 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | $1,095,055 | $7,766,063 |
| 2021 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | $937,104 | $5,480,919 |
| 2020 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | — | — |
| 2019 | Merck & Co., Inc. (MRK) | M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories | — | — |